Prothena | Kontanter Og Tilsvarende

Cash And Equivalent Endring Dato
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Exelixis USD 396.86M 67.62M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Prothena Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.